Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Shares Issued
Ratios

Phio Pharmaceuticals (PHIO) Other Gross PP&E Adjustments (2016 - 2021)

Phio Pharmaceuticals' Other Gross PP&E Adjustments history spans 10 years, with the latest figure at -$313000.0 for Q3 2021.

  • For Q3 2021, Other Gross PP&E Adjustments rose 26.87% year-over-year to -$313000.0; the TTM value through Sep 2021 reached -$313000.0, up 26.87%, while the annual FY2020 figure was -$1.8 million, 6.73% up from the prior year.
  • Other Gross PP&E Adjustments reached -$313000.0 in Q3 2021 per PHIO's latest filing, up from -$342000.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$313000.0 in Q3 2021 to a low of -$1.9 million in Q4 2019.
  • Average Other Gross PP&E Adjustments over 5 years is -$806846.2, with a median of -$538000.0 recorded in 2019.
  • Peak YoY movement for Other Gross PP&E Adjustments: grew 29.35% in 2017, then tumbled 37.03% in 2019.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$1.3 million in 2017, then fell by 3.89% to -$1.4 million in 2018, then tumbled by 37.03% to -$1.9 million in 2019, then increased by 6.73% to -$1.8 million in 2020, then soared by 82.36% to -$313000.0 in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Other Gross PP&E Adjustments are -$313000.0 (Q3 2021), -$342000.0 (Q2 2021), and -$371000.0 (Q1 2021).